Patent · US Active

Proteolytic enzyme formulations

US8287858B2 · kind B2 · utility

1Cited by
2References
10Claims
0Family size

Inventor

Key dates

Filing dateAug 9, 2007
Grant dateOct 16, 2012
Priority date
Expiry dateJun 27, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Preferred embodiments of the present invention relate to proteolytic enzyme formulations. More specifically, several embodiments relate a proteolytic formulation comprising fungal protease, papain, bromelain, fungal pancreatin, nattokinase, protease-S, amylase, lipase, rutin, ginger, and CMIK-pH, to facilitate digestion, metabolism, degradation of target compounds, and systemic enzymatic action.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.